Zentalis Pharma Stock (NASDAQ: ZNTL) stock price, news, charts, stock research, profile.
You can purchase shares of Zentalis Pharma (NASDAQ:ZNTL) through any online brokerage.
Other companies in Zentalis Pharma’s space includes: Precigen (NASDAQ:PGEN), Sage Therapeutics (NASDAQ:SAGE), Tevogen Bio Holdings (NASDAQ:TVGN), Anika Therapeutics (NASDAQ:ANIK) and TScan Therapeutics (NASDAQ:TCRX).
Zentalis Pharma has a consensus price target of $18.10.
The stock price for Zentalis Pharma (NASDAQ: ZNTL) is $3.47 last updated November 15, 2024 at 4:00 PM EST.
There are no upcoming dividends for Zentalis Pharma.
Zentalis Pharma’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Zentalis Pharma.
Zentalis Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.